Latest News about ENLV
Recent news which mentions ENLV
   12 Health Care Stocks Moving In Monday's Intraday Session
   
  
  
  August 18, 2025
  From Benzinga
 
   Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
   
  
  
  April 29, 2024
  From Benzinga
 
   Tesla To $180? Here Are 10 Top Analyst Forecasts For Friday
   
  
  
  April 12, 2024
  From Benzinga
 
   Nasdaq Jumps 250 Points; Crude Oil Down 1%
   
  
  
  April 11, 2024
  From Benzinga
 
   Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
   
  
  
  April 11, 2024
  From Benzinga
 
   Dow Dips 100 Points; CarMax Earnings Miss Views
   
  
  
  April 11, 2024
  From Benzinga
 From Benzinga
 Tickers 
   ENLV
  
  
  From InvestorPlace
 
   Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
   
  
  
  December 26, 2023
  From Benzinga
 
   Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
   
  
  
  December 22, 2023
  From Benzinga
 
   Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
   
  
  
  November 03, 2023
  From Benzinga
 
   This Biotech Is Bringing Balance To The Body – How Homeostasis Is Critical To Fighting Everything From Sepsis To Cancer
   
  June 16, 2023
  Tickers 
   ENLV
  
  
  From Benzinga
 From Benzinga
 
   Enlivex, Beigene Collaborate To Test A New Combination Treatment To Fight Advanced-Stage Solid Tumors
   
  
  
  April 11, 2023
  From Benzinga
 
   Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
   
  
  
  April 10, 2023
  From Benzinga
 
   FDA Clears Enlivex Therapeutics' IND Application To Study Allocetra™ in Patients with Advanced Solid Malignancies
   
  November 29, 2022
  Tickers 
   ENLV
  
  
  From Benzinga
 
   First Patients Dosed in Phase I/II Trial of Enlivex's Off-the-Shelf Cell Therapy Candidate, AllocetraTM
   
  
  
  November 22, 2022
  From Benzinga
 
   Enlivex Doses First Patient in Phase I/II Trial to Evaluate Allocetra™ for Advanced Solid Tumor Treatment
   
  November 15, 2022
  Tickers 
   ENLV
  
  
  From Benzinga
 
   A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial
   
  
  
  November 01, 2022
  From Benzinga
 
   What's Next For Cell Therapy In Oncology? Enlivex (NASDAQ: ENLV) Says It Has The Answers
   
  
  
  October 25, 2022
  From Benzinga
 
   Israeli Ministry Of Health Clears Way For Human Trials Of AllocetraTM, A Proprietary Off-the-Shelf Immunotherapy For Solid Tumors
   
  
  
  October 06, 2022
  From Benzinga
 
   Roger Pomerantz And Shai Novik Say They're Racing To Change The Odds Of Cancer Treatments
   
  
  
  July 14, 2022
  From Benzinga
 
   Changing The Landscape Of Cancer Therapy With Macrophages? How One Israeli Company Reports It's Looking To Do Just That
   
  
  
  July 05, 2022
  From Benzinga
 
   Reprogramming Imbalanced Macrophage Populations May Play A Key Role In Resolving Cancer And Various Inflammatory Disorders
   
  June 23, 2022
  Tickers 
   ENLV
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   51 Biggest Movers From Yesterday
   
  
  
  April 07, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Thursday
   
  
  
  February 03, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.